Cargando…
Everolimus induced pneumonitis in a lung transplant recipient
Everolimus is a mechanistic target of rapamycin inhibitor used for the treatment of various cancers and prevention of allograft rejection in solid organ transplantation. We present a case of a lung transplant recipient on everolimus who was admitted with generalized weakness, hypoxia and new onset b...
Autores principales: | Arunachalam, Ambalavanan, Ali, Syed Rizwan, Wakefield, Brett J, Lane, Charles R, Mehta, Atul C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915951/ https://www.ncbi.nlm.nih.gov/pubmed/29713487 http://dx.doi.org/10.1093/omcr/omy008 |
Ejemplares similares
-
Everolimus associated interstitial pneumonitis in a liver transplant patient
por: Siddiqui, Atif S., et al.
Publicado: (2016) -
Post-transplant lymphoproliferative disorder of the bladder in a lung transplant recipient
por: Grewal, Harpreet Singh, et al.
Publicado: (2018) -
Spontaneous pneumothorax in a single lung transplant recipient-a blessing in disguise: A case report
por: Deshwal, Himanshu, et al.
Publicado: (2020) -
Everolimus and papillomavirus lesions in female renal transplant recipient: A case report
por: Simundic, T., et al.
Publicado: (2018) -
Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
por: Sibertin-Blanc, Camille, et al.
Publicado: (2013)